http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103417507-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32
filingDate 2013-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103417507-B
titleOfInvention Budesonide pharmaceutical composition
abstract The invention belongs to field of pharmaceutical preparations, relate to the Budesonide pharmaceutical composition that a kind of release is stable, it is characterized in that comprising (a) Cn 21 -Cn 30 fatty alcohol or the lipotropy substrate of ester that formed of fatty acid or fatty acid and alcohol; B () can form the hydrophilic matrix of hydrophilic gel; (c) amphiphilic compound; The coating of (d) outside coating one deck acid resisting material.
priorityDate 2013-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425654805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416129817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13296868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549237
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163923531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92024010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465679407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457169682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420229795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530952

Total number of triples: 53.